A detailed history of Quest Partners LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Quest Partners LLC holds 1,552 shares of BPMC stock, worth $146,120. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,552
Previous 1,671 7.12%
Holding current value
$146,120
Previous $180 Million 20.29%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$84.1 - $120.5 $10,007 - $14,339
-119 Reduced 7.12%
1,552 $144 Million
Q2 2024

Aug 06, 2024

SELL
$85.18 - $108.78 $2,299 - $2,937
-27 Reduced 1.59%
1,671 $180 Million
Q1 2024

May 09, 2024

BUY
$73.17 - $99.79 $124,242 - $169,443
1,698 New
1,698 $161 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.62B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.